Objective: To compare clinical outcomes in laborers who have undergone open transforaminal interbody fusion (TLIF) and minimally invasive transforaminal interbody fusion (MIS TLIF). Methods: 78 patien
Abbreviations: IMP, Investigational Medical Product; a complete remission was achieved 50 days after the IMP infusion b the patient received 2nd IMP infusion upon relapse on day+327 and died 203 days